Understand the source comparison
Is Cartalax Legal?: Peptide vs Pharmaceutical Comparison
| Category | Cartalax (Research Peptide) | FDA-Approved Pharmaceutical | Dietary Supplement | Bottom Line ||—|—|—|—|| FDA Approval Required | No—legal as research chemical only | Yes—requires Phase I–III trials + NDA | No—GRAS or NDI notification sufficient |
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- | Category | Cartalax (Research Peptide) | FDA-Approved Pharmaceutical | Dietary Supplement | Bottom Line ||—|—|—|—|| FDA Approval Required | No—legal as research chemical only | Yes—requires Phase I–III trials + NDA | No—GRAS or NDI notification sufficient | Cartalax bypasses approval by staying in research category || Human Consumption Permitted | No—federal law prohibits unless IND filed | Yes—once approved for specific indication | Yes—if GRAS or listed as dietary ingredient | Consuming Cartalax is illegal without IND authorization || Labeling Requirements | Must state "For Research Use Only" | Must include FDA-approved prescribing information | Must comply with DSHEA labeling rules | Mislabeling Cartalax for human use triggers FDA enforcement || Seller Compliance Standards | COA, purity ≥98%, no therapeutic claims | cGMP manufacturing, adverse event reporting, FDA inspections | cGMP compliance, no drug claims, NDI if novel | Research peptide sellers face fewer regulations but stri
- The most important distinction: Cartalax legal status is preserved only when it remains in the research category. The moment a buyer consumes the peptide or a seller markets it for ingestion, it crosses into the drug category and loses legal protection.